Genolution's latest marketcap:
As of 06/26/2025, Genolution's market capitalization has reached $31.32 M. According to our data, Genolution is the 32976th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 31.32 M |
| Revenue (ttm) | 5.82 M |
| Net Income (ttm) | -6,552,465.51 |
| Shares Out | 18.07 M |
| EPS (ttm) | -0.36 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Genolution's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩31.32 M | 9.05% | 32976 |
| 12/30/2024 | ₩40.17 B | -45.41% | 32199 |
| 12/28/2023 | ₩73.59 B | -15.58% | 26941 |
| 12/29/2022 | ₩87.18 B | -42.33% | 24700 |
| 12/30/2021 | ₩151.16 B | 15.54% | 21576 |
| 12/30/2020 | ₩130.83 B | 473.44% | 19549 |
| 12/30/2019 | ₩22.81 B | 15.08% | 26468 |
| 12/28/2018 | ₩19.83 B | -4.68% | 25898 |
| 12/28/2017 | ₩20.8 B | 25639 |
Company Profile
About Genolution Inc.
Genolution Inc. is a biotechnology company specializing in molecular diagnostics and RNA-based research solutions. Headquartered in Seoul, South Korea, the company operates both domestically and internationally, providing innovative products and services for genetic research and disease prevention.
Core Products & Services
- Molecular Diagnostics: Offers automated extraction systems and specialized kits for DNA/RNA isolation from various samples, including:
- Nextractor (automatic extraction system)
- FFPE, whole blood, buccal swab, and pathogen-specific kits (RV, TB/NTM, STD, HPV, HBV, CMV/EBV)
- Rice, plant, and cell extraction kits
- RNAi Services: Specializes in gene expression inhibition through:
- siRNA/shRNA synthesis services
- Long dsRNA synthesis for gene silencing in living organisms
Company Background
Founded in 2006, Genolution has established itself as a key player in RNA interference technologies and molecular diagnostic solutions, serving research and clinical applications worldwide.
Frequently Asked Questions
-
What is Genolution's (KOSDAQ-225220) current market cap?As of 06/26/2025, Genolution (including the parent company, if applicable) has an estimated market capitalization of $31.32 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Genolution (KOSDAQ-225220) rank globally by market cap?Genolution global market capitalization ranking is approximately 32976 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.